1 / 24

Streptococcus agalactiae (GBS)

Streptococcus agalactiae (GBS). Characters of Streptococci Gram positive cocci 1 µ m in diameter Chains or pairs Usually capsulated Non motile Non spore forming Fastidious Catalase negative (Staphylococci are catalase positive). Streptococci. Streptococcus agalactiae (GBS).

lbradshaw
Download Presentation

Streptococcus agalactiae (GBS)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Streptococcus agalactiae(GBS)

  2. Characters of Streptococci Gram positive cocci 1µm in diameter Chains or pairs Usually capsulated Non motile Non spore forming Fastidious Catalase negative (Staphylococci are catalase positive) Streptococci

  3. Streptococcus agalactiae(GBS) • Physiology and Structure • Gram (+) streptococci • Facultative anaerobe • β –hemolytic (1-2% are nonhemolytic) • Classified by B antigen

  4. Streptococcus agalactiae

  5. Streptococcus agalactiae • Epidemiology • Site of colonization: • Lower gastrointestinal tract • Genitourinary tract • 10% to 30% of pregnant women are carriers. • 60% of infants born to colonized mothers become infected with mothers’ organisms. • This can lead to pneumonia, bacteremia, and meningitis

  6. Streptococcus agalactiae • Epidemiology cont. • Infections in men and non-pregnant women: • Primarily skin and soft-tissue • Bacteremia • Urosepsis (UTI with bacteremia) • Pneumonia • Conditions that predispose disease in adults: • Diabetes mellitus • Cancer • Alcoholism

  7. Pathogenesis Fig. 1. Stages in the molecular and cellular pathogenesis of neonatal group B Streptococcal (GBS) infection. Doran, Kelly S. & Nizet, Victor. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Molecular Microbiology  2004;54:23-31.

  8. Antiphagocytic properties Capsule-deficient mutants diminished virulence in animal models Sialic acid residues on capsule inhibit the binding of opsonically-active C3 component of complement to the cell surface blocking activation of the alternative pathway Transplacental passage of type-specific anticapsular IgG antibody from mother to infant is an important protective factor against invasive disease Virulence FactorGBS Surface Polysaccharide Capsule http://medicine.ucsd.edu/NizetLab

  9. Virulence FactorGBS β-hemolysin • Cytotoxic to pulmonary epithelial and endothelial cells • Pulmonary injury and alveolar protein exudate in early-onset pneumonia • Activity is blocked by surfactant phospholipid • Increased risk of premature, surfactant-deficient neonates for severe pneumonia • Induces cytokine release and nitric oxide production in macrophages • Stimulate elements of the sepsis cascade

  10. Virulence FactorC5a-peptidase • Cleaves and inactivates the complement-derived neutrophil chemoattractant C5a • C5a-peptidase-deficient mutants are more rapidly cleared from the lungs of infected animals when compared to the isogenic wild-type strain

  11. Hemolysis on Blood agar -hemolysis -hemolysis -hemolysis

  12. Bacitracin sensitivity • Principle: • Bacitracin test is used for presumptive identification of group A • To distinguish between S. pyogenes (susceptible to B) & non group A such as S. agalactiae (Resistant to B) • Bacitracin will inhibit the growth of gp A Strep. pyogenes giving zone of inhibition around the disk • Procedure: • Inoculate BAP with heavy suspension of tested organism • Bacitracin disk (0.04 U) is applied to inoculated BAP • After incubation, any zone of inhibition around the disk is considered as susceptible

  13. CAMP test • Principle: • Group B streptococci produce extracellular protein (CAMP factor) • CAMP act synergistically with staph. -lysin to cause lysis of RBCs • Procedure: • Single streak of Streptococcus to be tested and a Staph. aureus are made perpendicular to each other • 3-5 mm distance was left between two streaks • After incubation, a positive result appear as an arrowhead shaped zone of complete hemolysis • S. agalactiae is CAMP test positive while non gp B streptococci are negative

  14. CAMP test

  15. CAMP Factor Test S. aureus (Sphingomyelinase C) Group B Streptococcus (CAMP Factor) Group A Streptococcus Enhanced Zone of Hemolysis

  16. Optochin Susceptibility Test Optochin resistant S. viridans Optochin susceptible S. pneumoniae

  17. Differentiation between -hemolytic streptococci

  18. Hippurase NEG

  19. Grp B Streptococci and Campylobacter Hippurase POS

  20. Streptococcus agalactiae • Diagnosis • Culturing • Antigen Detection • DNA (PCR) test • Treatment • Penicillin G • Pregnant women are give IV 4 hours before delivery

  21. Culture– Gold Standard Selective broth medium (SMB or Lim Broth) PCR (Berger, et al 2000) Comparable in sensitivity to culture in extremely controlled laboratory environment Limited studied of clinical practice Immunoassay Enzyme and Optical Poor sensitivity Antigen detection may assist with diagnosis of CSF infection Diagnosis and Screening Bergeron MG, et al. Rapid detection of GBS in pregnant women at delivery. NEJM 2000;343:175.

More Related